Skip to main content

Table 4 Lipid and Inflammatory Measures at Week 0 and Week 16

From: Efficacy of a meal replacement diet plan compared to a food-based diet plan after a period of weight loss and weight maintenance: a randomized controlled trial

Measurement Week MD Group
Mean ± SD
Within Group
Δ p-value
Week FB Group
Mean ± SD
Within Group
Δ p-value
Between Group
Δ p-value
Total Cholesterol 0 (n = 39) 191.2 ± 39.5 p = 0.841 0 (n = 40) 187.5 ± 43.0 p = 0.687 p = 0.409
(mg/dl) 16 (n = 25) 181.3 ± 40.4   16 (n = 20) 184.9 ± 45.9   
HDL 0 (n = 39) 52.0 ± 16.0 p = 0.843 0 (n = 40) 51.8 ± 18.0 p = 0.261 p = 0.62
(mg/dl) 16 (n = 25) 51.6 ± 11.3   16 (n = 20) 48.2 ± 11.3   
LDL 0 (n = 39) 117.3 ± 31.8 p = 0.253 0 (n = 40) 108.8 ± 32.0 p = 0.779 p = 0.396
(mg/dl) 16 (n = 25) 111.4 ± 34.4   16 (n = 19) 110.7 ± 37.6   
VLDL 0 (n = 38) 21.9 ± 13.0 p = 0.026 0 (n = 37) 27.9 ± 17.9 p = 0.01 p = 0.652
(mg/dl) 16 (n = 24) 17.5 ± 9.8   16 (n = 20) 26.1 ± 16.4   
Triglycerides 0 (n = 39) 109.2 ± 63.7 p = 0.061 0 (n = 40) 134.7 ± 86.8 p = 0.009 p = 0.502
(mg/dl) 16 (n = 25) 91.8 ± 52.7   16 (n = 20) 130.4 ± 81.6   
CRP 0 (n = 38) 5.7 ± 4.8 p = 0.200 0 (n = 39) 7.1 ± 9.4 p = 0.018 p = 0.45
(mg/L) 16 (n = 25) 3.6 ± 2.9   16 (n = 20) 4.3 ± 4.7   
ULP 0 (n = 44) 6.1 ± 2.2 p = 0.684 0 (n = 44) 5.5 ± 1.7 p = 0.538 p = 0.973
(micromol/g creatinine) 16 (n = 27) 6.2 ± 2.2   16 (n = 20) 5.3 ± 2.4   
  1. Δ = Change from baseline to 16 weeks.
  2. = Secondary outcomes.